“…Moreover, in a cohort FCD II case, the density of activated microglial cells significantly correlates with the duration of epilepsy, as well as with the frequency of seizures before surgical resection . Moreover, the number of activated microglial cells and CD3/CD8 positive T cells, as well as the expression of the major histocompatibility complex class I (MHC-I) in neuronal cells and the expression of complement components, IL1b and chemokines, was significantly higher in FCD type II than in FCD type I cortical specimens (Ravizza et al 2006;Iyer et al 2010a;Prabowo et al 2013a), supporting the notion that these two types of FCD are pathologically distinct (Aronica and Crino 2014). In FCD II, there is also evidence of activation of the plasminogen system (Iyer et al 2010b), overexpression of HMGB1 and its receptors (TLR2, TLR4, and RAGE) (Zurolo et al 2011), and focal BBB disruption (Prabowo et al 2013a).…”